ncRNA name
ASAP1
Specific or universal ncRNAs
Specific ncRNAs
Class
Circular RNA
Biomarker
None
Biomarker application
Upstream regulatory factors
EIF4A3
Downstream target
NRAS/MEK1/ERK1-2
Cancer name
Glioblastoma
Cancer site
qRT-PCR,Western blot,Luciferase assay
Treatment type
Chemotherapy
Drug
Temozolomide
Impact of wild-type ncRNA on chemotherapy resistance
Up
Impact of knockdown of ncRNA on chemotherapy resistance
Impact of overexpression of ncRNA on chemotherapy resistance
ncRNA differential expression in
cancer
patients vs. healthy people
Not available
Number of patients
Not available
Male patients
Not available
Female patients
Not available
Age range and number
Not available
PMID
Description
EIF4A3-induced circular RNA ASAP1 promotes tumorigenesis and temozolomide resistance of glioblastoma via NRAS/MEK1/ERK1-2 signaling
Tissue resource
primary glioblastoma specimens and recurrent glioblastoma specimens
drug-related glioblastoma cell lines N3S
drug-related glioblastoma cell lines N3T3rd
drug-related glioblastoma cell lines U251
drug-related glioblastoma cell lines U251T3rd
Experiment
None
Institute
the First Affiliated Hospital of Nanjing Medical University
Country
China
Continent
Asia